. Safety and efficacy of rivastigmine in children with Down syndrome: A double blind placebo controlled trial. Am J Med Genet A. 2016 Jun;170(6):1545-55. Epub 2016 Apr 8 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Rivastigmine